Symbol="IBRX"
AssetType="Common Stock"
Name="Immunitybio Inc"
Description="ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy. "
CIK="1326110"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="3530 JOHN HOPKINS COURT, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="922108000"
EBITDA="-347424992"
PERatio="None"
PEGRatio="None"
BookValue="-1.213"
DividendPerShare="0"
DividendYield="0"
EPS="-0.96"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-625.04"
ReturnOnAssetsTTM="-0.625"
ReturnOnEquityTTM="0"
RevenueTTM="586000"
GrossProfitTTM="240000"
DilutedEPSTTM="-0.96"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="24.71"
AnalystTargetPrice="4.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4822.33"
PriceToBookRatio="-"
EVToRevenue="5498.73"
EVToEBITDA="-8.89"
Beta="-0.311"
num_52WeekHigh="7.8"
num_52WeekLow="1.21"
num_50DayMovingAverage="2.69"
num_200DayMovingAverage="3.608"
SharesOutstanding="435985000"
DividendDate="None"
ExDividendDate="None"
symbol="IBRX"
open="2.18"
high="2.19"
low="2.00"
price="2.01"
volume="2785447.00"
latest_trading_day="2023-08-04"
previous_close="2.12"
change="-0.10"
change_percent="-4.9645%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="4541648"
Change_recent_avg="0.02"
Delta_recent_avg="0.32"
Variance_recent_avg="0.16"
Change_ratio_recent_avg="0.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="489"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0116.jpeg"
image_negative_thumbnail_id_2="501"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0104.jpeg"
image_neutral_thumbnail_id_1="591"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_neutral_thumbnail_id_2="534"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_positive_thumbnail_id_1="707"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0001.jpeg"
image_positive_thumbnail_id_2="613"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0095.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
